IVVD
Invivyd Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$226.85M
P/E Ratio
—
EPS
$-0.29
Beta
0.63
52W High
$3.07
52W Low
$0.48
50-Day MA
$1.33
200-Day MA
$1.70
Dividend Yield
—
Profit Margin
-138.90%
Forward P/E
44.64
PEG Ratio
—
About Invivyd Inc.
Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases in the United States. The company is headquartered in Waltham, Massachusetts.
Fundamentals
| Revenue (TTM) | $55.87M |
| Gross Profit (TTM) | $51.92M |
| EBITDA | $-81.16M |
| Operating Margin | -313.90% |
| Return on Equity | -60.30% |
| Return on Assets | -29.60% |
| Revenue/Share (TTM) | $0.25 |
| Book Value | $0.72 |
| Price-to-Book | 1.12 |
| Price-to-Sales (TTM) | 4.06 |
| EV/Revenue | 0.919 |
| EV/EBITDA | 0.78 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 21.60% |
| Shares Outstanding | $294.61M |
| Float | $214.30M |
| % Insiders | 7.07% |
| % Institutions | 83.87% |
Historical Volatility
HV 10-Day
82.30%
HV 20-Day
79.75%
HV 30-Day
100.87%
HV 60-Day
109.68%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($10.00 target)
3
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026